Patients with hematological malignancy and need hematopoietic transplantation (autologous or allogeneic)
Conditions
Interventions
To take nutritional supplements containing amino acids.
Sponsors
Kyoto Prefectural University of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with hematological malignancy who need hematopoietic transplantation.
Exclusion criteria
Exclusion criteria: Patients who reject to participate in this trial, or who are in condition of being unable to make conscious judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mucositis, diarrhea, and nausea was graded according to NCI-CTCAE 4.0 (at the point of discharge or two months from intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| periods for opioids-use, fasting and discharge, change of body weight, laboratory data, overall survival, incidence of GVHD | — |
Countries
Japan
Contacts
Public ContactYuji Shimura
Kyoto Prefectural University of Medicine Dept. of Hematology
Outcome results
None listed